Cosmetic plastic surgery boosts your confidence the way you look. And increase in self-confidence in the look can encourage you to focus your energy on other areas like family and career. There may be certain flaws in your body and face that makeup, diet and exercise can’t help mask. There you should look into the ultimate in makeover, i.e., cosmetic plastic surgery.
While 62 percent of older women experience dry eye, only 16 percent know it’s linked to menopause, a new survey shows.
Periodontal therapy may help diabetic patients improve sugar control, according to a new study.
Women who undergo an ovary removal may have the risk of facing dementia – a disorder of the brain that sometimes causes emotional disturbances and personality change.
Patients who underwent a minimally invasive procedure to reduce their risk of a stroke by clearing plaque from neck arteries had unexpected gains in memory and mental skills, according to a study that will be presented today at a medical conference in Toronto.
Extensive removal of lymph nodes appears to boost the five-year survival of stomach cancer patients, Taiwanese researchers report.
Gastric surgery to treat obese patients is associated with long-term reductions in blood pressure, which are most pronounced in patients who have untreated high blood pressure before surgery.
African American women are more likely to die from breast cancer, and minorities in general do not receive the best treatment for the disease compared with white women, according to two studies published in the Journal of Clinical Oncology.
A procedure known as the “middle cranial fossa” approach can help preserve hearing when surgeons remove small acoustic neuromas — benign tumors that grow on the nerves that connect the brain to ear.
The Food and Drug Administration (FDA) announced the approval of Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with squamous cell cancer of the head and neck (SCCHN) that can not be removed by surgery (unresectable SCCHN). This is the first drug approved for head and neck cancer that has shown a survival benefit in this population. Erbitux was also approved today for use alone (monotherapy) to treat patients whose head and neck cancer has spread (metastasized) despite the use of standard chemotherapy.